ATTAIN-MAINTAIN y el futuro del manejo secuencial de la obesidad | Highlights ADA 2026
Dr. Aarón Borja presented the lecture "ATTAIN-MAINTAIN and the Future of Sequential Obesity Management," delivered during the Highlights ADA 2026 scientific update session, organized by the Ecuadorian Society of Endocrinology, Metabolism, Diabetes, and Nutrition – Pichincha Chapter. This lecture reviewed the latest findings of the ATTAIN-MAINTAIN program and its impact on the sequential management of obesity, a strategy that aims to optimize weight loss, promote long-term maintenance of results, and improve clinical outcomes through a personalized therapeutic approach. This presentation also analyzes new evidence on the use of pharmacological therapies and their integration into modern obesity treatment, based on the advances presented at the ADA Scientific Sessions 2026. This presentation is part of an academic conference where Ecuadorian specialists shared and analyzed the main developments presented during the American Diabetes Association (ADA) Scientific Sessions 2026, strengthening continuing medical education and promoting clinical practice based on the best scientific evidence. 📍 Organized by: Ecuadorian Society of Endocrinology, Metabolism, Diabetes and Nutrition – Pichincha Chapter. 🔔 Subscribe to our channel to access more conferences, scientific sessions, and updated content on endocrinology, diabetes, metabolism, and nutrition. Follow us on our social media to learn about our upcoming academic activities and scientific events. #ADA2026 #HighlightsADA2026 #Obesity #ATTAINMAINTAIN #Endocrinology #Diabetes #Metabolism #ContinuingMedicalEducation #EvidenceBasedMedicine #EcuadorianSocietyOfEndocrinology

Presentación de Resultados del Proyecto de Investigación ISAIN

Cholesterol, statins, and cardiovascular risk: what is the current situation? | Dr. Sergio Mejía

Sesión UVIRESIS 09/07/26: infección fúngica en la UCI

Is Insulin Resistance the Initial Lesion or a Secondary Consequence? | ADA Highlights

Onco-Diabetology 2026: Metabolic Challenges from Diagnosis to Survivorship | ADA HIGHLIGHTS

Gisela Valcárcel confesses: the infidelity of Roberto Martínez, Ethel, and Magaly #cafeconlachevez

BALAGUER, LOS 12 AÑOS Y LA MUERTE DE SAGRARIO DIAZ EN LA UASD

Inflation, Deficits, Interest Rates: Warning, Immediate Danger!

AI and the Battle for the Soul with Iain McGilchrist - Lecture 1: Information is Not Understanding

Big Pharma's Trillion Dollar Deception on Mental Health | Joanna Moncrief

AJ Styles On Retirement, Gunther, Hall Of Fame, John Cena, One More Match?

DAY 8 VP Sara Impeachment—NBI Director MATIBAG as Prosecution Witness!

WEGOVY: Lo que debes saber | ¿Dosis? ¿Duración del tratamiento? ¿Cómo evitar el EFECTO REBOTE?💉🩺

Geopolitical Portrait of Belarus

Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)

Lo que piensas no siempre es real | David del Rosario, investigador en neurociencia

Ozempic (Semaglutide) After Age 50? The Truth They Don't Tell You

Así será el colapso Económico y Demográfico de Occidente (Santiago Niño Becerra)

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

